ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,722,007 | -14.4% | 523,280 | -17.0% | 12.30% | -25.7% |
| Q2 2023 | $12,525,651 | +1.3% | 630,380 | -12.7% | 16.55% | +18.3% |
| Q1 2023 | $12,369,230 | -12.5% | 722,080 | 0.0% | 13.99% | +3.8% |
| Q4 2022 | $14,131,106 | +33.0% | 722,080 | +8.4% | 13.47% | +21.4% |
| Q3 2022 | $10,627,000 | +7.9% | 665,880 | -7.0% | 11.09% | +0.5% |
| Q2 2022 | $9,851,000 | -13.2% | 715,880 | 0.0% | 11.04% | +5.8% |
| Q1 2022 | $11,354,000 | +5.0% | 715,880 | +44.5% | 10.44% | +23.6% |
| Q4 2021 | $10,812,000 | – | 495,280 | – | 8.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |